Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent Rajkumar

Showing results (391-400 of 566) with videos related to

Pageof 57
Sort By:
American Journal of Hematology|August 11, 2016
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myelomaPaolo Milani, S Vincent Rajkumar, Giampaolo Merlini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 2, 2012
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseasesNelson Leung, Morie Gertz, Robert A Kyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myelomaMartha Q Lacy, Suzanne R Hayman, Morie A Gertz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 29, 2008
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathyMartha Q Lacy, Angela Dispenzieri, Suzanne R Hayman, et al.
Blood Cancer Journal|May 15, 2023
Conditional survival in multiple myeloma and impact of prognostic factors over timeNadine H Abdallah, Alexandra N Smith, Susan Geyer, et al.
Blood Cancer Journal|August 7, 2025
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresisElham Askari, Angela Dispenzieri, Francis K Buadi, et al.
American Journal of Hematology|February 10, 2017
Hematology patient reported symptom screen to assess quality of life for AL amyloidosisRahma Warsame, Shaji K Kumar, Morie A Gertz, et al.
Blood Advances|November 13, 2024
Retreatment of multiple myeloma with previously refractory drugsUtkarsh Goel, Charalampos Charalampous, Prashant Kapoor, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 24, 2019
Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosisEli Muchtar, Angela Dispenzieri, Dragan Jevremovic, et al.
Leukemia|October 17, 2018
Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapseSurbhi Sidana, Nidhi Tandon, Angela Dispenzieri, et al.
Pageof 57

Showing results (391-400 of 566) with videos related to

Sort By:
Pageof 57
American Journal of Hematology|August 11, 2016
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myelomaPaolo Milani, S Vincent Rajkumar, Giampaolo Merlini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 2, 2012
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseasesNelson Leung, Morie Gertz, Robert A Kyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myelomaMartha Q Lacy, Suzanne R Hayman, Morie A Gertz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 29, 2008
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathyMartha Q Lacy, Angela Dispenzieri, Suzanne R Hayman, et al.
Blood Cancer Journal|May 15, 2023
Conditional survival in multiple myeloma and impact of prognostic factors over timeNadine H Abdallah, Alexandra N Smith, Susan Geyer, et al.
Blood Cancer Journal|August 7, 2025
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresisElham Askari, Angela Dispenzieri, Francis K Buadi, et al.
American Journal of Hematology|February 10, 2017
Hematology patient reported symptom screen to assess quality of life for AL amyloidosisRahma Warsame, Shaji K Kumar, Morie A Gertz, et al.
Blood Advances|November 13, 2024
Retreatment of multiple myeloma with previously refractory drugsUtkarsh Goel, Charalampos Charalampous, Prashant Kapoor, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 24, 2019
Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosisEli Muchtar, Angela Dispenzieri, Dragan Jevremovic, et al.
Leukemia|October 17, 2018
Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapseSurbhi Sidana, Nidhi Tandon, Angela Dispenzieri, et al.
Pageof 57